References
Giuffrida P, Corazza GR, Di Sabatino A. Old and new lymphocyte players in inflammatory bowel disease. Dig Dis Sci. 2018;63:277–288.
Goldberg R, Prescott N, Lord GM, MacDonald TT, Powell N. The unusual suspects–innate lymphoid cells as novel therapeutic targets in IBD. Nat Rev Gastroenterol Hepatol. 2015;12:271–283.
Treiner E. Mucosal-associated invariant T cells in inflammatory bowel diseases: bystanders, defenders, or offenders? Front Immunol. 2015;6:27.
Andreu-Ballester JC, Amigó-García V, Catalán-Serra I, et al. Deficit of gammadelta T lymphocytes in the peripheral blood of patients with Crohn’s disease. Dig Dis Sci. 2011;56:2613–2622.
Catalan Serra I, Bruland T, Sandvik A, et al. Gammadelta T cells deficiency in the peripheral blood of patients with Crohn’s disease: inverse correlation with clinical and endoscopical activity. Gastroenterology. 2017;5(Suppl1):S616.
Mann ER, McCarthy NE, Peake ST, et al. Skin- and gut-homing molecules on human circulating γδT cells and their dysregulation in inflammatory bowel disease. Clin Exp Immunol. 2012;170:122–130.
McCarthy NE, Hedin CR, Sanders TJ, et al. Azathioprine therapy selectively ablates human Vδ2+ T cells in Crohn’s disease. J Clin Invest. 2015;125(3215–25):41.
Kadivar M, Petersson J, Svensson L, Marsal J. CD8αβ+ γδT cells: a novel T cell subset with a potential role in inflammatory bowel disease. J Immunol. 2016;197:4584–4592.
Deusch K, Lüling F, Reich K, Classen M, Wagner H, Pfeffer K. A major fraction of human intraepithelial lymphocytes simultaneously expresses the gamma/delta T cell receptor, the CD8 accessory molecule and preferentially uses the V delta 1 gene segment. Eur J Immunol. 1991;21:1053–1059.
Chien YH, Meyer C, Bonneville M. γδT cells: first line of defense and beyond. Annu Rev Immunol. 2014;32:121–155.
Catalan-Serra I, Sandvik AK, Bruland T, Andreu-Ballester JC. Gammadelta T cells in Crohn’s disease: a new player in the disease pathogenesis? J Crohns Colitis. 2017. https://doi.org/10.1093/ecco-jcc/jjx039.
Inagaki-Ohara K, Chinen T, Matsuzaki G, et al. Mucosal T cells bearing TCR gammadelta play a protective role in intestinal inflammation. J Immunol. 2004;173:1390–1398.
Hoffmann JC, Pawlowski NN, Grollich K, Loddenkemper C, Zeitz M, Kühl AA. Gammadelta T lymphocytes: a new type of regulatory T cells suppressing murine 2,4,6-trinitrobenzene sulphonic acid [TNBS]-induced colitis. Int J Colorectal Dis. 2008;23:909–920.
Andreu-Ballester JC, Garcia-Ballesteros C, Amigo V, et al. Microsporidia and its relation to Crohn’s disease. A retrospective study. PLoS One. 2013;8:e62107.
Dart RJ, Vantourout P, Laing A, et al. DOP075 Colonic gamma delta T-cells respond innately to NKG2D ligands and are grossly dysregulated in active inflammatory bowel disease. J Crohns Colitis. 2018;12(Suppl. 1):S081. https://doi.org/10.1093/ecco-jcc/jjx180.112.
Li J, Ueno A, Iacucci M, et al. Crossover subsets of CD4(+) T lymphocytes in the intestinal lamina propria of patients with Crohn’s disease and ulcerative colitis. Dig Dis Sci. 2017;62:2357–2368.
Alfen JS, Larghi P, Facciotti F, et al. Intestinal IFN-γ-producing type 1 regulatory T cells coexpress CCR5 and programmed cell death protein 1 and downregulate IL-10 in the inflamed guts of patients with inflammatory bowel disease. J Allergy Clin Immunol. 2018 Jan 31. (Epub ahead of print).
Paroni M, Magarotto A, Tartari S, et al. Uncontrolled IL-17 production by intraepithelial lymphocytes in a case of non-IPEX autoimmune enteropathy. Clin Transl Gastroenterol. 2016;7:e182.
Backert I, Koralov SB, Wirtz S, et al. STAT3 activation in Th17 and Th22 cells controls IL-22-mediated epithelial host defense during infectious colitis. J Immunol. 2014;193:3779–3791.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
None.
Rights and permissions
About this article
Cite this article
Catalan-Serra, I., Andreu-Ballester, J.C., Bruland, T. et al. Gammadelta T Cells: Unconventional T Cells Involved in IBD Pathogenesis. Dig Dis Sci 63, 1977–1979 (2018). https://doi.org/10.1007/s10620-018-5059-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10620-018-5059-7